In addition to providing compassionate patient care, our clinicians are committed to advancing the field of gastroenterology through clinical research, including clinical trials.
°ÅÀÖÊÓƵ trials are research studies that are vital for determining whether discoveries made in basic science research laboratories are effective for improving patient care.
Patients who visit °ÅÀÖÊÓƵ, including the DIGEST program, have access to a wide range of clinical trials that are evaluating new diagnostic and therapeutic approaches.
There are several clinical trials related to the DIGEST program that are currently active:
- A Multicenter Randomized Trial of Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients with Barrett’s Esophagus Undergoing Surveillance (The SWAT-BE Study) 23-02025718
- A Phase 3, Double-Blind, Randomized, Two-Phase, Active Controlled Study to Evaluate the Efficacy and Safety of Tegoprazan in Patients With Erosive Esophagitis 22-10025272
- The Role of the Microbiome and Notch Signaling in Esophageal Adenocarcinoma 21-02023380
You can visit the website for a list of clinical trials in open recruitment.